Both Pfizer And GSK RSV Vaccines Set For Approval – But Could Next Readouts Give One The Edge?

Longer Term Data Ready Soon

 
• By Andrew McConaghie
  
Older person vaccine
Both vaccines look set for approval in time for the fall/winter RSV season, but broad uptake will depend on long-term data. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip